Free Trial
CVE:QPT

Quest PharmaTech (QPT) Stock Price, News & Analysis

Quest PharmaTech logo
C$0.03 0.00 (0.00%)
As of 04/1/2025 03:55 PM Eastern

About Quest PharmaTech Stock (CVE:QPT)

Key Stats

Today's Range
C$0.03
C$0.04
50-Day Range
C$0.02
C$0.04
52-Week Range
C$0.02
C$0.04
Volume
699,986 shs
Average Volume
79,877 shs
Market Capitalization
C$5.07 million
P/E Ratio
N/A
Dividend Yield
6.15%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.

Remove Ads
Receive QPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter.

QPT Stock News Headlines

Quest PharmaTech Inc (QPT)
Trump… a socialist?
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Quest PharmaTech Announces Results from AGM
See More Headlines

QPT Stock Analysis - Frequently Asked Questions

Quest PharmaTech's stock was trading at C$0.03 at the beginning of the year. Since then, QPT stock has increased by 0.0% and is now trading at C$0.03.
View the best growth stocks for 2025 here
.

Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athenex (ATNX), Athersys (ATHX) and Antibe Therapeutics (ATE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:QPT
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-2,880,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$38,871.00
Cash Flow
C$0.00 per share
Price / Cash Flow
20.00
Book Value
C$0.14 per share
Price / Book
0.21

Miscellaneous

Free Float
N/A
Market Cap
C$5.07 million
Optionable
Not Optionable
Beta
0.14
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (CVE:QPT) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners